SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-18-011072
Filing Date
2018-08-14
Accepted
2018-08-14 17:17:28
Documents
47
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0618_citiuspharma.htm 10-Q 295522
2 CERTIFICATION f10q0618ex31-1_citiuspharma.htm EX-31.1 10101
3 CERTIFICATION f10q0618ex31-2_citiuspharma.htm EX-31.2 10089
4 CERTIFICATION f10q0618ex32-1_citiuspharma.htm EX-32.1 4853
  Complete submission text file 0001213900-18-011072.txt   2596954

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE ctxr-20180630.xml EX-101.INS 376687
6 XBRL SCHEMA FILE ctxr-20180630.xsd EX-101.SCH 41011
7 XBRL CALCULATION FILE ctxr-20180630_cal.xml EX-101.CAL 33094
8 XBRL DEFINITION FILE ctxr-20180630_def.xml EX-101.DEF 123640
9 XBRL LABEL FILE ctxr-20180630_lab.xml EX-101.LAB 318621
10 XBRL PRESENTATION FILE ctxr-20180630_pre.xml EX-101.PRE 220205
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38174 | Film No.: 181018882
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1